Intercept Pharmaceuticals: Q3 Earnings Insights

Intercept Pharmaceuticals ICPT reported its Q3 earnings results on Tuesday, November 1, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.

Intercept Pharmaceuticals beat estimated earnings by 69.2%, reporting an EPS of $7.8 versus an estimate of $4.61.

Revenue was down $15.24 million from the same period last year.

Last quarter the company missed on EPS by $0.21 which was followed by a 13.08% increase in the share price the next day.

Here's a look at Intercept Pharmaceuticals's past performance:

Quarter	Q2 2022	Q1 2022	Q4 2021	Q3 2021
EPS Estimate	-0.04	-0.90	-1.10	-1.09
EPS Actual	-0.25	-0.58	-1.23	-0.63
Revenue Estimate	95.72M	90.49M	92.38M	83.02M
Revenue Actual	71.76M	88.58M	92.40M	92.83M

To track all earnings releases for Intercept Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.